Guardant Health, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Guardant Health, Inc. (GH), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are GH insiders buying or selling?
In the last 12 months, Guardant Health, Inc. insiders reported 0 open-market purchases ($0) and 49 sales ($140.1M) — net selling of $140.1M. Since March 2019, Trabud has recorded 259 Form 4 filings for GH: 8 buys ($65.2M) and 251 sells ($2.9B).
Source: SEC EDGAR Form 4
What stands out
- No Guardant Health, Inc. insider made an open-market purchase in the last 12 months; the 49 reported open-market sales totaled $140.1M.
Key Statistics (March 2019 – Oct 15, 2026)
Total Form 4 filings
259
SEC EDGAR
Insider filers
24
Insider buys (8)
$65.2M
Insider sells (251)
$2.9B
Insider sentiment
Net sellingNet insider flow of $2.9B in net selling since March 2019, and $140.1M in net selling over the last 12 months.
Recent GH insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Alex M Azar II | Director | Sale | 69 | $159.89 | $11.0K | SEC ↗ |
| Sep 17, 2026 | Darya Chudova | Chief Technology Officer | Sale | 7.7K | $178.00 | $1.4M | SEC ↗ |
| Sep 17, 2026 | Steve E. Krognes | Director | Sale | 6.7K | $175.74 | $1.2M | SEC ↗ |
| Sep 17, 2026 | Alex M Azar II | Director | Sale | 826 | $175.00 | $144.6K | SEC ↗ |
| Sep 17, 2026 | Musa Tariq | Director | Sale | 116 | $175.00 | $20.3K | SEC ↗ |
| Sep 14, 2026 | Kumud Kalia | Chief Information Officer | Sale | 4.0K | $158.05 | $632.2K | SEC ↗ |
| Aug 24, 2026 | Amirali Talasaz | Co-Chief Executive Officer | Sale | 37.5K | $169.16 | $6.3M | SEC ↗ |
| Aug 18, 2026 | Musa Tariq | Director | Sale | 116 | $156.45 | $18.1K | SEC ↗ |
| Aug 13, 2026 | Terilyn J. Monroe | Chief People Officer | Sale | 46.3K | $165.12 | $7.6M | SEC ↗ |
| Aug 11, 2026 | Chris Freeman | Chief Commercial Officer | Sale | 63.6K | $169.58 | $10.8M | SEC ↗ |
| Aug 6, 2026 | Medina Manuel Hidalgo | Director | Sale | 1.7K | $164.24 | $279.2K | SEC ↗ |
| Aug 5, 2026 | Ian T Clark | Director | Sale | 14.2K | $158.92 | $2.3M | SEC ↗ |
| Jul 16, 2026 | Musa Tariq | Director | Sale | 116 | $163.29 | $18.9K | SEC ↗ |
| Jun 30, 2026 | Kumud Kalia | Chief Information Officer | Sale | 600 | $131.18 | $78.7K | SEC ↗ |
| Jun 30, 2026 | Amirali Talasaz | Co-Chief Executive Officer | Sale | 260.0K | $151.20 | $39.3M | SEC ↗ |
| Jun 23, 2026 | Musa Tariq | Director | Sale | 2.0K | $131.16 | $255.9K | SEC ↗ |
| Jun 23, 2026 | Myrtle S Potter | Director | Sale | 1.6K | $131.16 | $204.1K | SEC ↗ |
| Jun 16, 2026 | Musa Tariq | Director | Sale | 116 | $130.19 | $15.1K | SEC ↗ |
| Jun 15, 2026 | Kumud Kalia | Chief Information Officer | Sale | 3.4K | $130.24 | $445.2K | SEC ↗ |
| Jun 12, 2026 | Kumud Kalia | Chief Information Officer | Sale | 5.0K | $130.41 | $652.0K | SEC ↗ |
| Jun 8, 2026 | Eltoukhy Helmy | Co-Chief Executive Officer | Sale | 100.0K | $126.30 | $12.6M | SEC ↗ |
| Jun 8, 2026 | Michael Brian Bell | Chief Financial Officer | Sale | 2.0K | $128.62 | $257.2K | SEC ↗ |
| Jun 5, 2026 | Steve E. Krognes | Director | Sale | 9.3K | $132.51 | $1.2M | SEC ↗ |
| Jun 4, 2026 | Meghan V. Joyce | Director | Sale | 10.0K | $126.98 | $1.3M | SEC ↗ |
| May 29, 2026 | Medina Manuel Hidalgo | Director | Sale | 1.0K | $130.06 | $130.1K | SEC ↗ |
Showing the 25 most recent of 259 Form 4 filings for Guardant Health, Inc..
Most active GH insiders
- Ian T Clark42 filings
- Amirali Talasaz41 filings
- Stanley J Meresman36 filings
- Eltoukhy Helmy23 filings
- Musa Tariq22 filings
Ask anything about GH insider activity
Use Trabud's AI agent to query Guardant Health, Inc.'s Form 4 history in plain English — "Show me GH CEO purchases this year" or compare it against any other ticker.
Open the AI agentGH insider trading FAQ
Are Guardant Health, Inc. insiders buying or selling?
In the last 12 months, Guardant Health, Inc. insiders reported 0 open-market purchases ($0) and 49 sales ($140.1M) — net selling of $140.1M. Since March 2019, Trabud has recorded 259 Form 4 filings for GH: 8 buys ($65.2M) and 251 sells ($2.9B). Over the full record that is net selling of $2.9B.
How many insiders trade GH stock?
24 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Guardant Health, Inc.. The most recent filing was accepted on Oct 15, 2026.
Where does Trabud get GH insider trading data?
All GH insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.